A M Stamm, W E Dismukes. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Amphotericin B/adverse effectsAmphotericin B/metabolismAmphotericin B/therapeutic useAntifungal Agents/adverse effectsAntifungal Agents/metabolismAntifungal Agents/therapeutic useAspergillosis/drug therapyBlastomycosis/drug therapyCandidiasis/drug therapyChromoblastomycosis/drug therapyCoccidioidomycosis/drug therapyCryptococcosis/drug therapyFlucytosine/metabolismFlucytosine/therapeutic useHistoplasmosis/drug therapyHumansImidazoles/adverse effectsImidazoles/metabolismImidazoles/therapeutic useKetoconazoleLung Diseases, Fungal/drug therapyMiconazole/metabolismMiconazole/therapeutic useMycoses/drug therapyNausea/chemically inducedPiperazines/adverse effectsPiperazines/metabolismPiperazines/therapeutic useVomiting/chemically induced
Substances: See more » Antifungal AgentsImidazolesPiperazinesMiconazoleAmphotericin BFlucytosineKetoconazole
Year: 1983 PMID: 6303713 DOI: 10.1378/chest.83.6.911
Source DB: PubMed Journal: Chest ISSN: 0012-3692 Impact factor: 9.410